Ovasave, a Hub71-based FemTech startup focused on fertility and hormonal health, has announced the successful completion of its pre-seed funding round. The company raised $1.2 million from a mix of regional and international investors.

The round was led by PlusVC, Annex Investments, and New York-based 25 Madison. Additional funding came from strategic angel investors and family offices in the UAE and Saudi Arabia.

The funding reflects growing investor confidence and demand for innovation in women’s health across the region.

Founded in 2023, Ovasave offers a digital-first platform for women, covering fertility testing, egg freezing, hormone management, and menopause care. The platform integrates at-home hormone testing, virtual consultations, personalized supplement protocols, and access to top fertility clinics.

The startup has also introduced corporate fertility benefits programs to help organizations support employee reproductive health.

According to Ovasave, the $1.2 million capital will be used to:

• Expand across the GCC region
• Scale corporate partnerships
• Launch the next version of its mobile app

The upcoming app update will feature menstrual cycle tracking, symptom monitoring, AI-driven treatment protocols, and access to care.

Ovasave will also expand its services to include support for perimenopause and menopause, addressing a previously overlooked stage of women’s health.

The funding announcement aligns with ongoing healthcare reforms and national support for women’s health in the UAE. Ovasave is registered with the Department of Health – Abu Dhabi and is backed by Abu Dhabi’s tech ecosystem, Hub71.

Majd Abu Zant, Co-founder of Ovasave, noted that Abu Dhabi’s focus on healthcare, innovation, and entrepreneurship provides the right environment for high-impact ventures. He confirmed Ovasave’s expansion into Saudi Arabia and the wider MENA region.

FemTech Analytics reported that the MENA FemTech market is projected to reach $3.8 billion by 2031, growing at a CAGR of 15%.

Ovasave Co-founder and CEO Torkia Mahloul emphasized the need for timely fertility and hormonal care. She said the funding will help scale a platform offering personalized and accessible care for women across different life stages.

The startup is also committed to public education, with campaigns like “Fertility Your Way,” in partnership with Merck Gulf, offering free AMH screenings to over 500 women in the UAE.

Ovasave has partnered with employers such as Aldar, Boston Consulting Group, and WeWork to raise awareness around fertility in the workplace.

The company reported that investor confidence and regional demand signal a shift in how fertility and hormonal health are perceived. Ovasave aims to lead innovation in women’s health across the Middle East.

Related post

View all